About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Dual Time Point PET in Lymphoma

Dual Time Point PET in Lymphoma

NCT01894945·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Karen Juul Mylam, MD
CONTACT
0045 6541 3186 karen.mylam@rsyd.dk

Lead

Odense University Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age\>18 years
Planned for curative treatment

You may not be if

Previously treatment with chemotherapy or irradiation
Primary CNS lymphoma
Recurrent lymphoma
Transformation from indolent lymphoma
Presence of diabetes mellitus, HIV, chronic inflammatory disease or infections
Pregnancy or lactation

The record

StatusUnknown

PhaseNo phase

Taking part30

StartedMar 2012

UpdatedJul 10, 2013

Conditions

Hodgkin's and Non-Hodgkin's Lymphoma

Where2

Odense University Hospital, Department of hematology
Odense, Denmark
Roskilde Hospital
Roskilde, Denmark